Darolutamide Tied to Symptom Control in Non-Metastatic Prostate Cancer
Darolutamide (Nubeqa) was linked with a decrease in locally invasive procedures, as well as local urinary and bowel symptoms, in patients with nonmetastatic (nm) castration-resistant prostate cancer (CRPC), according to analysis of the ARAMIS trial. The drug, compared with placebo, was also associated with a delayed deterioration in patient quality of life (QoL) related to […]
Less-Invasive Tibial Nerve Stimulator Quiets Overactive Bladder
A minimally invasive, coin-sized implantable device was effective in treating overactive bladder (OAB) syndrome, researchers found. In a prospective, single-arm, open-label study funded by the device’s manufacturer, the novel, leadless tibial nerve stimulator achieved at least a 50% reduction in urgency urinary incontinence in two-thirds of the patients, reported Alexandra Rogers, MD, of Sansum Clinic […]